BioSpace News Archive

BioCapital

Compassion & Choices Praises D.C. Health’s Progress in Implementing Medical Aid-in-Dying Act

Compassion & Choices today praised D.C. Health for releasing two years of reports today showing it is making progress in implementing the D.C. Death with Dignity Act, despite repeated congressional attempts to repeal the law since it took effect on Feb. 18, 2017.

August 2, 2019

·

4 min read

BioCapital

Acerus Announces Temporary Unavailability of NATESTO® in Canada and South Korea

Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today announced that it will voluntarily replace certain NATESTO® lots released in the Canadian and South Korean markets, which is expected to cause temporary shortages in those markets.

August 2, 2019

·

3 min read

Pharm Country

ONC201 In the Spotlight at Upcoming Symposium on Brain Cancer

Oncoceutics, Inc. announced that a series of presentations at the 2019 DIPG/DMG Symposium to be held August 2-3 in Sydney, Australia, will highlight ONC201 as a promising treatment for specific types of lethal brain cancer

August 2, 2019

·

2 min read

Deals

BIOCARDIA ANNOUNCES PRICING OF $10.0 MILLION PUBLIC OFFERING AND UPLISTING TO NASDAQ

BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the pricing of its public offering of 1,666,667 units at a price to the public of $6.00 per unit.

August 2, 2019

·

3 min read

Business

First M6 Cervical Disc Replacement Surgery by Dr. Fabien Bitan Scheduled in New York for Friday, August 2

Dr. Fabien Bitan, Chief of Spine Surgery at Lenox Hill Hospital, a leading clinical researcher in the field of spinal arthroplasty will perform the implantation of the M6-C™ artificial cervical disc on Friday, August 2nd, 2019.

August 2, 2019

·

4 min read

Policy

ROSEN, A HIGHLY RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ACRS

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Aclaris Therapeutics, Inc. from May 8, 2018 through June 20, 2019, inclusive.

August 2, 2019

·

2 min read

Drug Development

GlycoMimetics Reports Top-line Results From Pfizer’s Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease

GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel: Evaluating Safety, Efficacy and Time to Discharge pivotal study did not meet its primary or key secondary efficacy endpoints.

August 2, 2019

·

4 min read

Job Trends

Accelerate Diagnostics Expands Antimicrobials in New CE-Marked Accelerate PhenoTest™ BC kit

Accelerate Diagnostics, Inc. announced the release and CE marking of its latest Accelerate PhenoTest™ BC kit, declaring conformity to the European Directive 98/79/EC on in vitro diagnostic medical devices.

August 2, 2019

·

3 min read

Deals

Exact Sciences to participate in August investor conference

Exact Sciences Corp. announced that company management will be presenting at the following investor conference and invited investors to participate by webcast.

August 2, 2019

·

4 min read

Mallinckrodt to Present at Wells Fargo Securities 2019 Healthcare Conference

Mallinckrodt Pharmaceuticals, a global biopharmaceutical company, will present on Thursday, Sept. 5, 2019, at the Wells Fargo Securities 2019 Healthcare Conference at the Westin Copley Place, 10 Huntington Ave., Boston.

August 2, 2019

·

2 min read